Safety Profiling of Tumor-targeted T Cell-Bispecific Antibodies with Alveolus Lung- and Colon-on-Chip.

Kerns, Jordan S; Belgur, Chaitra; Kanellias, Marianne; Manatakis, Dimitris V; Barrile, Riccardo; Tien-Street, Will; Ewart, Lorna; Gjorevski, Nikolche; Cabon, Lauriane

Kerns, Jordan S; Belgur, Chaitra; Kanellias, Marianne; Manatakis, Dimitris V; Barrile, Riccardo; Tien-Street, Will; Ewart, Lorna; Gjorevski, Nikolche; Cabon, Lauriane.

Afiliação

Kerns JS; Emulate Inc, Boston, United States.
Belgur C; Emulate Inc, Boston, United States.
Kanellias M; Emulate Inc, Boston, United States.
Manatakis DV; Emulate Inc, Boston, United States.
Barrile R; Emulate Inc, Boston, United States.
Tien-Street W; Emulate Inc, Boston, United States.
Ewart L; Emulate Inc, Boston, United States.
Gjorevski N; Emulate Inc, Boston, United States.
Cabon L; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.

Bio Protoc ; 13(1)2023 Jan 05.

Article em En | MEDLINE | ID: mdl-36789090

Palavras-chave

Alveolar biology; Cancer Immunotherapy; Cancer biology; Intestinal biology; Organoids; Organs-on-Chip; Preclinical safety; Primary cell models; Safety; T Cell bispecifics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Bio Protoc Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google